Lindsay Androski

All filings by Lindsay Androski on record concern Arbutus Biopharma Corporation. We count 6 filings; the first trade dates from 18 September 2026 and the latest from 1 October 2026.

Not one of the filings records a straightforward purchase or sale on the market. Such operations are usually part of compensation schedules, which makes them a weaker signal than an open-market trade.

Most recently, on 7 October 2026, the filings show a transaction worth €77k in Arbutus Biopharma Corporation. The median gap between a trade and its publication by SEDI is 5 days. This delay matters because a trade only becomes useful information once it is public. These figures are compiled from regulatory filings published by SEDI. They describe what insiders did and are not a recommendation.